Early research (Phase 1)Looking for participantsNCT07241039
What this trial is testing
Assess the Adverse Events, Change in Disease Activity, and How Oral ABBV-711 Tablets Move Through the Body as a Monotherapy and in Combination With Intravenously Infused Budigalimab (ABBV-181), in Adults With Advanced Squamous Tumors
Who this might be right for
Advanced Squamous Tumors
AbbVie 220